The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain ... health milestone in acute pain management,” Jacqueline Corrigan ...

a non-opioid, pain signal inhibitor and the first new class of pain medicine approved in more than 20 years, we have the opportunity to change the paradigm of acute pain management and establish a ...

Journavx (suzetrigine), a non-opioid pill for ... It’s not cleared for chronic pain. “Today’s approval is an important public health milestone in acute pain management,” said Jacqueline ...

oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an important public health milestone in acute pain management ...

"Suzetrigine’s non-opioid mechanism eliminates risks of misuse, addiction and respiratory depression, making it a safer alternative for acute pain management." In addition to acute pain ...

Jan. 31, 2025 – The FDA has approved a new non-opioid oral drug for acute pain in adults. It is the first new class of non-opioid pain medicine approved in over 20 years, providing effective ...

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management SILVER SPRING, Md., Jan. 30, 2025 /PRNewswire/ -- Today ...